Positive airway pressure treatment affects respiratory symptoms and gastro-oesophageal reflux: the Icelandic Sleep Apnea Cohort Study
- PMID: 37817868
- PMCID: PMC10561083
- DOI: 10.1183/23120541.00387-2023
Positive airway pressure treatment affects respiratory symptoms and gastro-oesophageal reflux: the Icelandic Sleep Apnea Cohort Study
Abstract
Aim: To study the effect of positive airway pressure (PAP) treatment on nocturnal gastro-oesophageal reflux (nGOR) and respiratory symptoms among clinical obstructive sleep apnoea (OSA) patients.
Methods: 822 patients newly diagnosed with OSA referred for PAP treatment were recruited. 732 patients had a 2-year follow-up visit with continuous PAP compliance data (366 full PAP users, 366 partial/non-PAP users). They answered questionnaires, including reporting of nGOR, sleep and respiratory symptoms and general health. Patients with nGOR symptoms once a week or more were defined as "with nGOR". Those without nGOR symptoms and nGOR medication were defined as "no nGOR". Others were defined as "possible nGOR".
Results: At 2-year follow-up, PAP treatment among full users resulted in decreased nGOR (adjusted OR 0.58, 95% CI 0.40-0.86) and wheezing (adjusted OR 0.56, 95% CI 0.35-0.88) compared with partial/non-PAP users. Decreased nGOR, among both full and partial/non-users of PAP treatment, was associated with a decrease in productive morning cough (adjusted OR 4.70, 95% CI 2.22-9.99) and a decrease in chronic bronchitis (adjusted OR 3.86, 95% CI 1.74-8.58), but not decreased wheezing (adjusted OR 0.90, 95% CI 0.39-2.08). A mediation analysis found that PAP treatment directly led to a decrease in wheezing, not mediated through nGOR. Conversely, PAP treatment decreased productive cough mediated through a decrease in nGOR.
Conclusion: In an unselected group of OSA patients, PAP treatment for 2 years was associated with a decrease in nGOR and respiratory symptoms. The PAP treatment itself was associated with less wheezing. A decrease in nGOR through PAP treatment was associated with a decrease in productive cough.
Copyright ©The authors 2023.
Conflict of interest statement
Conflict of interest: All authors have nothing to disclose.
Figures



Similar articles
-
Nocturnal gastro-oesophageal reflux, asthma and symptoms of OSA: a longitudinal, general population study.Eur Respir J. 2013 Jun;41(6):1347-54. doi: 10.1183/09031936.00052512. Epub 2012 Sep 27. Eur Respir J. 2013. PMID: 23018910
-
Nocturnal gastro-oesophageal reflux and respiratory symptoms are increased in sleep apnoea: comparison with the general population.BMJ Open Respir Res. 2024 Mar 25;11(1):e002192. doi: 10.1136/bmjresp-2023-002192. BMJ Open Respir Res. 2024. PMID: 38531547 Free PMC article.
-
Snoring and nocturnal reflux: association with lung function decline and respiratory symptoms.ERJ Open Res. 2019 May 28;5(2):00010-2019. doi: 10.1183/23120541.00010-2019. eCollection 2019 Apr. ERJ Open Res. 2019. PMID: 31149624 Free PMC article.
-
Cough in obstructive sleep apnoea.Pulm Pharmacol Ther. 2015 Dec;35:129-31. doi: 10.1016/j.pupt.2015.05.008. Epub 2015 Jun 9. Pulm Pharmacol Ther. 2015. PMID: 26068465 Review.
-
Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure.Cochrane Database Syst Rev. 2019 Dec 4;12(12):CD012803. doi: 10.1002/14651858.CD012803.pub2. Cochrane Database Syst Rev. 2019. PMID: 31797360 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials